• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用尿生物标志物推断单次血清肌酐测量的门诊患者中不存在急性肾疾病。

Employing urinary biomarkers to infer the absence of acute kidney disease in outpatients with a single serum creatinine measurement.

机构信息

Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei, Taiwan.

School of Life Science, National Taiwan Normal University, Taipei, Taiwan.

出版信息

Ren Fail. 2024 Dec;46(2):2427161. doi: 10.1080/0886022X.2024.2427161. Epub 2024 Nov 26.

DOI:10.1080/0886022X.2024.2427161
PMID:39593219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11610285/
Abstract

INTRODUCTION

In outpatient settings, it is challenging to exclude acute kidney disease (AKD) based on a single serum creatinine (SCr) measurement. This retrospective study aimed to explore the usefulness of urinary biomarkers and a novel functional biomarker, a spot urine creatinine-to-osmolality ratio (sUCr/Osm), for inferring the absence of AKD.

METHODS

The cohort was from the ASSESS-AKI Study. 'No AKD' was defined as the absence of a SCr increase ≥ 26.5 μmol/L between the preceding visit and the index visit, with a three-month interval. Urinary neutrophil gelatinase-associated lipocalin (UNGAL) was selected as the representative biomarker out of six known candidates. UNGAL levels < 100 ng/mL indicated a positive test. sUCr/Osm values ≥ 7.07 indicated a positive test.

RESULTS

Of the 1,570 participants, 38.0% were female. The mean age (mean ± SD) was 64.6 ± 13.0 years, and the mean SCr level was 102.5 ± 51.4 μmol/L. The area under the receiver operating characteristic curve for UNGAL in identifying 'No AKD' for all participants was 0.548 (95% confidence interval: 0.495-0.600), whereas that for sUCr/Osm was 0.578 (0.525-0.630). The sensitivity of UNGAL was 0.867 (0.849-0.884), with a positive predictive value of 0.917 (0.902-0.932) and an accuracy of 0.808 (0.788-0.827). The corresponding values of sUCr/Osm were 0.926 (0.912-0.939), 0.906 (0.891-0.921), and 0.845 (0.827-0.863). In individuals whose SCr-derived estimated glomerular filtration rate was < 60 mL/min/1.73 m, sUCr/Osm performed comparably to UNGAL.

CONCLUSION

Using sUCr/Osm to infer the absence of AKD in outpatients with a single SCr measurement may be as effective as using UNGAL.

摘要

简介

在门诊环境中,仅凭单次血清肌酐(SCr)测量排除急性肾损伤(AKD)具有挑战性。本回顾性研究旨在探讨尿生物标志物和一种新的功能性生物标志物,即即时尿肌酐/渗透压比值(sUCr/Osm),用于推断 AKD 不存在的价值。

方法

该队列来自 ASSESS-AKI 研究。“无 AKD”定义为在随访间隔三个月的情况下,与前一次就诊相比,就诊时 SCr 增加≥26.5 μmol/L。选择六种已知候选物中的中性粒细胞明胶酶相关脂质运载蛋白(UNGAL)作为代表性生物标志物。UNGAL 水平<100ng/mL 表示检测阳性。sUCr/Osm 值≥7.07 表示检测阳性。

结果

在 1570 名参与者中,38.0%为女性。平均年龄(平均值±标准差)为 64.6±13.0 岁,平均 SCr 水平为 102.5±51.4μmol/L。在所有参与者中,UNGAL 识别“无 AKD”的受试者工作特征曲线下面积为 0.548(95%置信区间:0.495-0.600),而 sUCr/Osm 的面积为 0.578(0.525-0.630)。UNGAL 的敏感性为 0.867(0.849-0.884),阳性预测值为 0.917(0.902-0.932),准确性为 0.808(0.788-0.827)。sUCr/Osm 的相应值为 0.926(0.912-0.939)、0.906(0.891-0.921)和 0.845(0.827-0.863)。在 SCr 衍生估算肾小球滤过率<60mL/min/1.73m2 的个体中,sUCr/Osm 的表现与 UNGAL 相当。

结论

在门诊患者中,使用 sUCr/Osm 推断单次 SCr 测量时 AKD 不存在,其效果可能与 UNGAL 相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/ee324e7a8637/IRNF_A_2427161_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/8f6d38a057c7/IRNF_A_2427161_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/410cf9936a74/IRNF_A_2427161_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/ee324e7a8637/IRNF_A_2427161_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/8f6d38a057c7/IRNF_A_2427161_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/410cf9936a74/IRNF_A_2427161_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbf/11610285/ee324e7a8637/IRNF_A_2427161_F0003_C.jpg

相似文献

1
Employing urinary biomarkers to infer the absence of acute kidney disease in outpatients with a single serum creatinine measurement.运用尿生物标志物推断单次血清肌酐测量的门诊患者中不存在急性肾疾病。
Ren Fail. 2024 Dec;46(2):2427161. doi: 10.1080/0886022X.2024.2427161. Epub 2024 Nov 26.
2
Integration of urinary neutrophil gelatinase-associated lipocalin with serum creatinine delineates acute kidney injury phenotypes in critically ill children.尿中性粒细胞明胶酶相关脂质运载蛋白与血清肌酐整合可区分危重症患儿急性肾损伤表型。
J Crit Care. 2019 Oct;53:1-7. doi: 10.1016/j.jcrc.2019.05.017. Epub 2019 May 28.
3
Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.中性粒细胞明胶酶相关脂质运载蛋白作为择期侵入性心脏手术后造影剂诱导的肾病的早期标志物
Clin Cardiol. 2016 Aug;39(8):464-70. doi: 10.1002/clc.22551. Epub 2016 May 13.
4
Persistent serum creatinine increase following contrast-induced acute kidney injury.对比剂诱导的急性肾损伤后血清肌酐持续升高。
Catheter Cardiovasc Interv. 2018 Jun;91(7):1185-1191. doi: 10.1002/ccd.27239. Epub 2017 Aug 11.
5
Biomarker-based acute kidney injury sub-phenotypes refine risk assessment in children undergoing cardiac surgery.基于生物标志物的急性肾损伤亚表型可优化心脏手术患儿的风险评估。
Pediatr Nephrol. 2025 Feb;40(2):523-531. doi: 10.1007/s00467-024-06541-z. Epub 2024 Sep 27.
6
Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.尿中性粒细胞明胶酶相关脂质运载蛋白可识别重症监护病房入院后发生急性肾损伤的危重症幼儿:一项前瞻性队列研究。
Crit Care. 2015 Apr 21;19(1):181. doi: 10.1186/s13054-015-0910-0.
7
Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.尿中性粒细胞明胶酶相关载脂蛋白预测择期冠状动脉介入治疗的慢性肾脏病患者对比剂诱导急性肾损伤的严重程度。
BMC Nephrol. 2013 Dec 5;14:270. doi: 10.1186/1471-2369-14-270.
8
Neutrophil gelatinase-associated lipocalin and acute kidney injury in endovascular aneurysm repair or open aortic repair: a pilot study.中性粒细胞明胶酶相关脂质运载蛋白与血管内动脉瘤修复或开放主动脉修复术后急性肾损伤:一项初步研究。
Biochem Med (Zagreb). 2018 Feb 15;28(1):010904. doi: 10.11613/BM.2018.010904. Epub 2018 Jan 10.
9
Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis.中性粒细胞明胶酶相关脂质运载蛋白(NGAL)能降低成本吗?一项针对急性肾损伤(AKI)诊断的尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)和血清肌酐(sCr)的成本分析。
PLoS One. 2017 May 19;12(5):e0178091. doi: 10.1371/journal.pone.0178091. eCollection 2017.
10
Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study.尿中性粒细胞明胶酶相关脂质运载蛋白是危重症儿童急性肾损伤的早期标志物:一项前瞻性队列研究。
Crit Care. 2007;11(4):R84. doi: 10.1186/cc6089.

引用本文的文献

1
Employing urinary biomarkers in predicting renal recovery three months after in-hospital acute kidney injury.利用尿液生物标志物预测住院期间急性肾损伤三个月后的肾功能恢复情况。
Ren Fail. 2025 Dec;47(1):2522975. doi: 10.1080/0886022X.2025.2522975. Epub 2025 Jul 10.

本文引用的文献

1
Effect of fluid replacement with green tea on body fluid balance and renal responses under mild thermal hypohydration: a randomized crossover study.轻度热脱水时用绿茶进行液体替代对体液平衡和肾脏反应的影响:一项随机交叉研究。
Eur J Nutr. 2023 Dec;62(8):3339-3347. doi: 10.1007/s00394-023-03236-3. Epub 2023 Aug 18.
2
Obesity, Hyperfiltration, and Early Kidney Damage: A New Formula for the Estimation of Creatinine Clearance.肥胖、高滤过和早期肾脏损害:一种新的估算肌酐清除率的公式。
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3280-3286. doi: 10.1210/clinem/dgad330.
3
Reference Intervals of Spot Urine Creatinine-to-Osmolality Ratio as a Surrogate of Urinary Creatinine Excretion Rate.
尿肌酐-渗透压比值的斑点尿参考区间可作为尿肌酐排泄率的替代指标。
Dis Markers. 2022 Jul 25;2022:3549047. doi: 10.1155/2022/3549047. eCollection 2022.
4
Considerations in Controlling for Urine Concentration for Biomarkers of Kidney Disease Progression After Acute Kidney Injury.急性肾损伤后控制尿浓度以评估肾病进展生物标志物的相关考量
Kidney Int Rep. 2022 Apr 6;7(7):1502-1513. doi: 10.1016/j.ekir.2022.03.026. eCollection 2022 Jul.
5
Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury.NephroCheck 和 NGAL 检测与标准护理相比用于诊断急性肾损伤的成本效益和信息价值分析。
BMC Nephrol. 2021 Dec 1;22(1):399. doi: 10.1186/s12882-021-02610-9.
6
2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement.2021年欧洲高血压学会诊室和诊室外血压测量实践指南。
J Hypertens. 2021 Jul 1;39(7):1293-1302. doi: 10.1097/HJH.0000000000002843.
7
Rule Out Acute Kidney Injury in the Emergency Department With a Urinary Dipstick.在急诊科使用尿试纸条排除急性肾损伤
Kidney Int Rep. 2020 Sep 18;5(11):1982-1992. doi: 10.1016/j.ekir.2020.09.006. eCollection 2020 Nov.
8
Circadian variation in renal blood flow and kidney function in healthy volunteers monitored with noninvasive magnetic resonance imaging.健康志愿者肾脏血流和肾功能的昼夜变化的无创磁共振成像监测。
Am J Physiol Renal Physiol. 2020 Dec 1;319(6):F966-F978. doi: 10.1152/ajprenal.00311.2020. Epub 2020 Oct 19.
9
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.急性疾病质量倡议共识会议关于急性肾损伤生物标志物的建议:共识声明。
JAMA Netw Open. 2020 Oct 1;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.
10
A long journey for acute kidney injury biomarkers.急性肾损伤生物标志物的漫漫求索之路。
Ren Fail. 2020 Nov;42(1):154-165. doi: 10.1080/0886022X.2020.1721300.